These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1828422)

  • 21. Hyperuricemia as a clue for central diabetes insipidus (lack of V1 effect) in the differential diagnosis of polydipsia.
    Decaux G; Prospert F; Namias B; Soupart A
    Am J Med; 1997 Nov; 103(5):376-82. PubMed ID: 9375705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant.
    Rosenthal W; Seibold A; Antaramian A; Gilbert S; Birnbaumer M; Bichet DG; Arthus MF; Lonergan M
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):429-36. PubMed ID: 7920187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment.
    Knoers N; Monnens LA
    Pediatr Nephrol; 1992 Sep; 6(5):476-82. PubMed ID: 1457333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colocalization of the gene for nephrogenic diabetes insipidus (DIR) and the vasopressin type 2 receptor gene (AVPR2) in the Xq28 region.
    van den Ouweland AM; Knoop MT; Knoers VV; Markslag PW; Rocchi M; Warren ST; Ropers HH; Fahrenholz F; Monnens LA; van Oost BA
    Genomics; 1992 Aug; 13(4):1350-2. PubMed ID: 1324225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Misfolded vasopressin V2 receptors caused by extracellular point mutations entail congential nephrogenic diabetes insipidus.
    Postina R; Ufer E; Pfeiffer R; Knoers NV; Fahrenholz F
    Mol Cell Endocrinol; 2000 Jun; 164(1-2):31-9. PubMed ID: 11026555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus.
    Wildin RS; Cogdell DE; Valadez V
    Kidney Int; 1998 Dec; 54(6):1909-22. PubMed ID: 9853256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans.
    Bankir L; Fernandes S; Bardoux P; Bouby N; Bichet DG
    J Am Soc Nephrol; 2005 Jul; 16(7):1920-8. PubMed ID: 15888562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The vasopressin type 2 receptor gene. Chromosomal localization and its role in nephrogenic diabetes insipidus.
    Seibold A; Rosenthal W; Bichet DG; Birnbaumer M
    Regul Pept; 1993 Apr; 45(1-2):67-71. PubMed ID: 8511369
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus.
    Rosenthal W; Seibold A; Antaramian A; Lonergan M; Arthus MF; Hendy GN; Birnbaumer M; Bichet DG
    Nature; 1992 Sep; 359(6392):233-5. PubMed ID: 1356229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus.
    Pan Y; Metzenberg A; Das S; Jing B; Gitschier J
    Nat Genet; 1992 Oct; 2(2):103-6. PubMed ID: 1303257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is testing with dDAVP useful in detecting carriers of the nephrogenic diabetes insipidus gene?
    Bichet DG; Arthus MF; Lonergan M
    Nephron; 1991; 58(3):372-3. PubMed ID: 1896107
    [No Abstract]   [Full Text] [Related]  

  • 32. Neurogenic diabetes insipidus: management with dDAVP (1-desamino-8-D arginine vasopressin).
    Cobb WE; Spare S; Reichlin S
    Ann Intern Med; 1978 Feb; 88(2):183-8. PubMed ID: 626447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus.
    Lolait SJ; O'Carroll AM; McBride OW; Konig M; Morel A; Brownstein MJ
    Nature; 1992 May; 357(6376):336-9. PubMed ID: 1534150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nephrogenic diabetes insipidus.
    Bichet DG
    Am J Med; 1998 Nov; 105(5):431-42. PubMed ID: 9831428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Null mutation in the vasopressin V2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus in the Hopewell kindred.
    Holtzman EJ; Kolakowski LF; O'Brien D; Crawford JD; Ausiello DA
    Hum Mol Genet; 1993 Aug; 2(8):1201-4. PubMed ID: 8401502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The abnormal quinine drinking aversion in the Brattleboro rat with diabetes insipidus is reversed by the vasopressin agonist DDAVP: a possible role for vasopressin in the motivation to drink.
    Laycock JF; Chatterji U; Seckl JR; Gartside IB
    Physiol Behav; 1994 Mar; 55(3):407-12. PubMed ID: 8190753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary vasopressin resistance in man and mouse.
    Moses AM; Scheinman SJ
    Ann N Y Acad Sci; 1993 Jul; 689():233-49. PubMed ID: 8373015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. V2 receptor antagonism of DDAVP-induced release of hemostasis factors in conscious dogs.
    Bernat A; Hoffmann P; Dumas A; Serradeil-le Gal C; Raufaste D; Herbert JM
    J Pharmacol Exp Ther; 1997 Aug; 282(2):597-602. PubMed ID: 9262320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes Insipidus.
    Lu HA
    Adv Exp Med Biol; 2017; 969():213-225. PubMed ID: 28258576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nephrogenic diabetes insipidus in sibling colts.
    Schott HC; Bayly WM; Reed SM; Brobst DF
    J Vet Intern Med; 1993; 7(2):68-72. PubMed ID: 8501698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.